{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:18:50Z","timestamp":1769257130379,"version":"3.49.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-024-10174-8","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T08:35:24Z","timestamp":1734770124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of adipose tissue on the development of multiple myeloma"],"prefix":"10.1007","volume":"52","author":[{"given":"Marcin","family":"Stanis\u0142awowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"1","key":"10174_CR1","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/s41467-020-16878-2","volume":"11","author":"KJ Suchacki","year":"2020","unstructured":"Suchacki KJ, Tavares AAS, Mattiucci D, Scheller EL, Papanastasiou G, Gray C et al (2020) Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat Commun 11(1):3097. https:\/\/doi.org\/10.1038\/s41467-020-16878-2","journal-title":"Nat Commun"},{"issue":"8","key":"10174_CR2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K (2016) Body fatness and cancer\u2013viewpoint of the IARC working group. New Engl J Med 375(8):794\u2013798. https:\/\/doi.org\/10.1056\/NEJMsr1606602","journal-title":"New Engl J Med"},{"issue":"9612","key":"10174_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569\u2013578. https:\/\/doi.org\/10.1016\/S0140-6736(08)60269-X","journal-title":"Lancet"},{"issue":"10","key":"10174_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1634\/theoncologist.2010-0206","volume":"15","author":"MA Lichtman","year":"2010","unstructured":"Lichtman MA (2010) Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 15(10):1083\u20131101. https:\/\/doi.org\/10.1634\/theoncologist.2010-0206","journal-title":"Oncologist"},{"issue":"36","key":"10174_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1200\/EDBK_159009","volume":"36","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV (2016) Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book 36(36):418\u2013423. https:\/\/doi.org\/10.1200\/EDBK_159009","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"10174_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. Am J Hematol 97(8):1086\u20131107. https:\/\/doi.org\/10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"issue":"12","key":"10174_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1159\/000520312","volume":"44","author":"M Heider","year":"2021","unstructured":"Heider M, Nickel K, H\u00f6gner M, Bassermann F (2021) Multiple myeloma: molecular pathogenesis and disease evolution. Oncol Res Treat 44(12):672\u2013681. https:\/\/doi.org\/10.1159\/000520312","journal-title":"Oncol Res Treat"},{"issue":"1","key":"10174_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci9010003","volume":"9","author":"SA Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, Kota V, Ajebo GH (2021) Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel) 9(1):3. https:\/\/doi.org\/10.3390\/medsci9010003","journal-title":"Med Sci (Basel)"},{"issue":"26","key":"10174_CR9","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33(26):2863\u20132869. https:\/\/doi.org\/10.1200\/JCO.2015.61.2267","journal-title":"J Clin Oncol"},{"issue":"18","key":"10174_CR10","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1182\/bloodadvances.2023010822","volume":"7","author":"R Choa","year":"2023","unstructured":"Choa R, Panaroni C, Bhatia R, Raje N (2023) It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma. Blood Adv 7(18):5510\u20135523. https:\/\/doi.org\/10.1182\/bloodadvances.2023010822","journal-title":"Blood Adv"},{"key":"10174_CR11","doi-asserted-by":"publisher","first-page":"1045002","DOI":"10.3389\/fimmu.2022.1045002","volume":"13","author":"A Oganesyan","year":"2022","unstructured":"Oganesyan A, Gregory A, Malard F, Ghahramanyan N, Mohty M, Kazandjian D, Mekinian A, Hakobyan Y (2022) Monoclonal gammopathies of clinical significance (MGCS): in pursuit of optimal treatment. Front Immunol 13:1045002. https:\/\/doi.org\/10.3389\/fimmu.2022.1045002","journal-title":"Front Immunol"},{"issue":"8","key":"10174_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346(8):564\u2013569. https:\/\/doi.org\/10.1056\/NEJMoa01133202","journal-title":"N Engl J Med"},{"issue":"6","key":"10174_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajh.24355","volume":"91","author":"B Boursi","year":"2016","unstructured":"Boursi B, Weiss BM, Haynes K, Mamtani R, Yang YX (2016) Reappraisal of risk factors for monoclonal gammopathy of undetermined significance. Am J Hematol 91(6):581\u2013584. https:\/\/doi.org\/10.1002\/ajh.24355","journal-title":"Am J Hematol"},{"issue":"7","key":"10174_CR14","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","volume":"28","author":"O Landgren","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R et al (2014) Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the national health and nutritional examination survey. Leukemia 28(7):1537\u20131542. https:\/\/doi.org\/10.1038\/leu.2014.34","journal-title":"Leukemia"},{"issue":"24","key":"10174_CR15","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","volume":"1","author":"M Thordardottir","year":"2017","unstructured":"Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Korde N et al (2017) Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv 1(24):2186\u20132192. https:\/\/doi.org\/10.1182\/bloodadvances.2017007609","journal-title":"Blood Adv"},{"issue":"7","key":"10174_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","volume":"116","author":"O Landgren","year":"2010","unstructured":"Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A et al (2010) Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 116(7):1056\u20131059. https:\/\/doi.org\/10.1182\/blood-2010-01-262394","journal-title":"Blood"},{"issue":"11","key":"10174_CR17","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.22968","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A (2007) Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer 121(11):2512\u20132516. https:\/\/doi.org\/10.1002\/ijc.22968","journal-title":"Int J Cancer"},{"issue":"11","key":"10174_CR18","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin A, Larsson SC (2011) Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 47(11):1606\u20131615. https:\/\/doi.org\/10.1016\/j.ejca.2011.01.020","journal-title":"Eur J Cancer"},{"issue":"5","key":"10174_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/jnci\/djw264","volume":"109","author":"SH Chang","year":"2017","unstructured":"Chang SH, Luo S, Thomas TS et al (2017) Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study. J Natl Cancer Inst 109(5):264. https:\/\/doi.org\/10.1093\/jnci\/djw264","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10174_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41408-022-00659-9","volume":"12","author":"G Kleinstern","year":"2022","unstructured":"Kleinstern G, Larson DR, Allmer C et al (2022) Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County. Minnesota Blood Cancer J 12(4):67. https:\/\/doi.org\/10.1038\/s41408-022-00659-9","journal-title":"Minnesota Blood Cancer J"},{"issue":"9","key":"10174_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00256-016-2425-4","volume":"45","author":"J Veld","year":"2016","unstructured":"Veld J, O\u2019Donnell EK, Reagan MR et al (2016) Abdominal adipose tissue in MGUS and multiple myeloma. Skeletal Radiol 45(9):1277\u20131283. https:\/\/doi.org\/10.1007\/s00256-016-2425-4","journal-title":"Skeletal Radiol"},{"issue":"6","key":"10174_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa1508808","volume":"374","author":"S Nair","year":"2016","unstructured":"Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV (2016) Clonal immunoglobulin against lysolipids in the origin of myeloma. N Engl J Med 374(6):555\u2013561. https:\/\/doi.org\/10.1056\/NEJMoa1508808","journal-title":"N Engl J Med"},{"issue":"3","key":"10174_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1615\/critrevoncog.2013006145","volume":"18","author":"PK Mistry","year":"2013","unstructured":"Mistry PK, Taddei T, vom Dahl S, Rosenbloom BE (2013) Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism. Crit Rev Oncog 18(3):235\u2013246. https:\/\/doi.org\/10.1615\/critrevoncog.2013006145","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"10174_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ejh.14105","volume":"111","author":"G Giuffrida","year":"2023","unstructured":"Giuffrida G, Markovic U, Condorelli A, Duminuco A, Calafiore V, Conticello C et al (2023) Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance. Eur J Haematol 111(6):922\u2013929. https:\/\/doi.org\/10.1111\/ejh.14105","journal-title":"Eur J Haematol"},{"issue":"6","key":"10174_CR25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.7150\/jca.69321","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Chen B, Shao R, Liu W, Xiong L, Li L, Lu Y (2022) A new prediction model integrated serum lipid profile for patients with multiple myeloma. J Cancer 13(6):1796\u20131807. https:\/\/doi.org\/10.7150\/jca.69321","journal-title":"J Cancer"},{"issue":"20","key":"10174_CR26","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.7150\/jca.31357","volume":"10","author":"L Liang","year":"2019","unstructured":"Liang L, Li J, Fu H, Liu X, Liu P (2019) Identification of high serum apolipoprotein a1 as a favorable prognostic indicator in patients with multiple myeloma. J Cancer 10(20):4852\u20134859. https:\/\/doi.org\/10.7150\/jca.31357","journal-title":"J Cancer"},{"issue":"7","key":"10174_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trecan.2020.03.001","volume":"6","author":"C Attan\u00e9","year":"2020","unstructured":"Attan\u00e9 C, Muller C (2020) Drilling for oil: tumor-surrounding adipocytes fueling cancer. Trends Cancer 6(7):593\u2013604. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.001","journal-title":"Trends Cancer"},{"issue":"2","key":"10174_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cancers13020217","volume":"13","author":"A Garc\u00eda-Ortiz","year":"2021","unstructured":"Garc\u00eda-Ortiz A, Rodr\u00edguez-Garc\u00eda Y, Encinas J, Maroto-Mart\u00edn E et al (2021) The role of tumor microenvironment in multiple myeloma development and progression. Cancers (Basel) 13(2):217. https:\/\/doi.org\/10.3390\/cancers13020217","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10174_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10555-022-10063-1","volume":"41","author":"BA Bunnell","year":"2022","unstructured":"Bunnell BA, Martin EC, Matossian MD, Brock CK et al (2022) The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer. Cancer Metastasis Rev 41(3):549\u2013573. https:\/\/doi.org\/10.1007\/s10555-022-10063-1","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"10174_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/cells12071030","volume":"12","author":"SD Alipoor","year":"2023","unstructured":"Alipoor SD, Chang H (2023) Exosomal miRNAs in the tumor microenvironment of multiple myeloma. Cells 12(7):1030. https:\/\/doi.org\/10.3390\/cells12071030","journal-title":"Cells"},{"key":"10174_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-med-051613-012328","volume":"66","author":"PJ Goodwin","year":"2015","unstructured":"Goodwin PJ, Stambolic V (2015) Impact of the obesity epidemic on cancer. Annu Rev Med 66:281\u2013296. https:\/\/doi.org\/10.1146\/annurev-med-051613-012328","journal-title":"Annu Rev Med"},{"key":"10174_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2018.03.011","volume":"118","author":"EV Morris","year":"2019","unstructured":"Morris EV, Edwards CM (2019) Bone marrow adiposity and multiple myeloma. Bone 118:42\u201346. https:\/\/doi.org\/10.1016\/j.bone.2018.03.011","journal-title":"Bone"},{"issue":"1","key":"10174_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","volume":"8","author":"E Terpos","year":"2018","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA (2018) Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J 8(1):7. https:\/\/doi.org\/10.1038\/s41408-017-0037-4","journal-title":"Blood Cancer J"},{"issue":"7","key":"10174_CR34","doi-asserted-by":"publisher","first-page":"52986","DOI":"10.15252\/embr.202152986","volume":"22","author":"M Onji","year":"2021","unstructured":"Onji M, Werschler N, Penninger J (2021) A critical relationship between bone and fat: the role of bone marrow adipose-derived RANKL in bone metabolism. EMBO Rep 22(7):52986. https:\/\/doi.org\/10.15252\/embr.202152986","journal-title":"EMBO Rep"},{"key":"10174_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fendo.2016.00067","volume":"7","author":"C Falank","year":"2016","unstructured":"Falank C, Fairfield H, Reagan MR (2016) Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front Endocrinol (Lausanne) 7:67. https:\/\/doi.org\/10.3389\/fendo.2016.00067","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10174_CR36","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.tranon.2023.101856","volume":"40","author":"X Wei","year":"2024","unstructured":"Wei X, Zhang Y, Wang Z, He Y, Ju S, Fu J (2024) Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment. Transl Oncol 40:101856. https:\/\/doi.org\/10.1016\/j.tranon.2023.101856","journal-title":"Transl Oncol"},{"key":"10174_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.18632\/oncotarget.28548","volume":"15","author":"BM El-Masri","year":"2024","unstructured":"El-Masri BM, Leka B, Mustapha F, Gundesen MT, Hinge M, Lund T, Andersen TL, Diaz-del Castillo M, Jafari A (2024) Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma. Oncotarget 15:20\u201326. https:\/\/doi.org\/10.18632\/oncotarget.28548","journal-title":"Oncotarget"},{"key":"10174_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","volume":"92","author":"A Tentolouris","year":"2023","unstructured":"Tentolouris A, Ntanasis-Stathopoulos I, Terpos E (2023) Obesity and multiple myeloma: emerging mechanisms and perspectives. Semin Cancer Biol 92:45\u201360. https:\/\/doi.org\/10.1016\/j.semcancer.2023.04.003","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10174_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12013-023-01185-6","volume":"82","author":"R Mallick","year":"2024","unstructured":"Mallick R, Basak S, Das RK, Banerjee A, Paul S, Pathak S, Duttaroy AK (2024) Fatty acids and their proteins in adipose tissue inflammation. Cell Biochem Biophys 82(1):35\u201351. https:\/\/doi.org\/10.1007\/s12013-023-01185-6","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"10174_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41375-021-01443-7","volume":"36","author":"R Parikh","year":"2022","unstructured":"Parikh R, Tariq SM, Marinac CR, Shah UA (2022) A comprehensive review of the impact of obesity on plasma cell disorders. Leukemia 36(2):301\u2013314. https:\/\/doi.org\/10.1038\/s41375-021-01443-7","journal-title":"Leukemia"},{"key":"10174_CR41","doi-asserted-by":"publisher","first-page":"912834","DOI":"10.3389\/fonc.2022.912834","volume":"12","author":"H Fairfield","year":"2023","unstructured":"Fairfield H, Condruti R, Farrell M, Di Iorio R, Gartner CA, Vary C et al (2023) Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells. Front Oncol 12:912834. https:\/\/doi.org\/10.3389\/fonc.2022.912834","journal-title":"Front Oncol"},{"issue":"3","key":"10174_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11914-017-0360-5","volume":"15","author":"L Soley","year":"2017","unstructured":"Soley L, Falank C, Reagan MR (2017) MicroRNA transfer between bone marrow adipose and multiple myeloma cells. Curr Osteoporos Rep 15(3):162\u2013170. https:\/\/doi.org\/10.1007\/s11914-017-0360-5","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10174_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1210\/er.2011-1015","volume":"33","author":"M Dalamaga","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS (2012) The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33(4):547\u2013594. https:\/\/doi.org\/10.1210\/er.2011-1015","journal-title":"Endocr Rev"},{"issue":"5","key":"10174_CR44","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/biomedicines11051290","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Mart\u00edn-Rodr\u00edguez A, Mart\u00ednez-Guardado I, Navarro-Jim\u00e9nez E, Laborde-C\u00e1rdenas CC, Tornero-Aguilera JF (2023) The role of adipokines in health and disease. Biomedicines 11(5):1290. https:\/\/doi.org\/10.3390\/biomedicines11051290","journal-title":"Biomedicines"},{"key":"10174_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.05.033","volume":"53","author":"A Allegra","year":"2018","unstructured":"Allegra A, Innao V, Gerace D, Allegra AG, Vaddinelli D, Bianco O, Musolino C (2018) The adipose organ and multiple myeloma: impact of adipokines on tumor growth and potential sites for therapeutic intervention. Eur J Intern Med 53:12\u201320. https:\/\/doi.org\/10.1016\/j.ejim.2018.05.033","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10174_CR46","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.3390\/ijms22062870","volume":"22","author":"TC Lin","year":"2021","unstructured":"Lin TC, Hsiao M (2021) Leptin and cancer: updated functional roles in carcinogenesis, therapeutic niches, and developments. Int J Mol Sci 22(6):2870. https:\/\/doi.org\/10.3390\/ijms22062870","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10174_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cen.12667","volume":"83","author":"CH Lee","year":"2015","unstructured":"Lee CH, Woo YC, Wang Y, Yeung CY, Xu A, Lam KSL (2015) Obesity, adipokines and cancer: an update. Clin Endocrinol (Oxf) 83(2):147\u2013156. https:\/\/doi.org\/10.1111\/cen.12667","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10174_CR48","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/oby.21894","volume":"25","author":"JN Hofmann","year":"2017","unstructured":"Hofmann JN, Mailankody S, Korde N, Wang Y, Tageja N, Costello R et al (2017) Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease. Obesity (Silver Spring) 25(8):1317\u20131320. https:\/\/doi.org\/10.1002\/oby.21894","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10174_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12902-022-00939-2","volume":"22","author":"R Liu","year":"2022","unstructured":"Liu R, Gao D, Lv Y, Zhai M, He A (2022) Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies. BMC Endocr Disord 22(1):29. https:\/\/doi.org\/10.1186\/s12902-022-00939-2","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"10174_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","volume":"20","author":"M Dalamaga","year":"2009","unstructured":"Dalamaga M, Karmaniolas K, Panagiotou A, Hsi A, Chamberland J, Dimas C et al (2009) Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer Causes Control 20(2):193\u2013199. https:\/\/doi.org\/10.1007\/s10552-008-9233-7","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10174_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/jbmr.3951","volume":"35","author":"EV Morris","year":"2020","unstructured":"Morris EV, Suchacki KJ, Hocking J, Cartwright R, Sowman A, Gamez B et al (2020) Myeloma cells down-regulate adiponectin in bone marrow adipocytes Via TNF-alpha. J Bone Miner Res 35(5):942\u2013955. https:\/\/doi.org\/10.1002\/jbmr.3951","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10174_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bjc.2017.282","volume":"117","author":"L Santo","year":"2017","unstructured":"Santo L, Teras LR, Giles GG, Weinstein SJ, Albanes D, Wang Y et al (2017) Circulating resistin levels and risk of multiple myeloma in three prospective cohorts. Br J Cancer 117(8):1241\u20131245. https:\/\/doi.org\/10.1038\/bjc.2017.282","journal-title":"Br J Cancer"},{"issue":"7","key":"10174_CR53","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","volume":"102","author":"J Pang","year":"2017","unstructured":"Pang J, Shi Q, Liu Z, He J, Liu H, Lin P, Cui J, Yang J (2017) Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression. Haematologica 102(7):1273\u20131280. https:\/\/doi.org\/10.3324\/haematol.2016.154062","journal-title":"Haematologica"},{"issue":"1","key":"10174_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/172460080401900107","volume":"19","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Sfiridaki A, Pappa CA, Moschandrea JA, Kandidakis E et al (2004) Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines. Int J Biol Markers 19(1):52\u201357. https:\/\/doi.org\/10.1177\/172460080401900107","journal-title":"Int J Biol Markers"},{"issue":"3","key":"10174_CR55","first-page":"241","volume":"28","author":"GE Pamuk","year":"2006","unstructured":"Pamuk GE, Demir M, Harmandar F, Ye\u015fil Y, Turgut B, Vural \u00d6 (2006) Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol 28(3):241\u2013244","journal-title":"Exp Oncol"},{"issue":"2","key":"10174_CR56","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/biomedicines11020644","volume":"11","author":"F Deepika","year":"2023","unstructured":"Deepika F, Bathina S, Armamento-Villareal R (2023) Novel adipokines and their role in bone metabolism: a narrative review. Biomedicines 11(2):644. https:\/\/doi.org\/10.3390\/biomedicines11020644","journal-title":"Biomedicines"},{"issue":"4","key":"10174_CR57","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3233\/CBM-160654","volume":"17","author":"M Maden","year":"2016","unstructured":"Maden M, Pamuk ON, Pamuk GE (2016) High apelin levels could be used as a diagnostic marker in multiple myeloma: a comparative study. Cancer Biomark 17(4):391\u2013396. https:\/\/doi.org\/10.3233\/CBM-160654","journal-title":"Cancer Biomark"},{"issue":"15","key":"10174_CR58","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.3390\/ijms20153750","volume":"20","author":"O Treeck","year":"2019","unstructured":"Treeck O, Buechler C, Ortmann O (2019) Chemerin and cancer. Int J Mol Sci 20(15):3750. https:\/\/doi.org\/10.3390\/ijms20153750","journal-title":"Int J Mol Sci"},{"key":"10174_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-018-0134-y","volume":"6","author":"M Westhrin","year":"2018","unstructured":"Westhrin M, Moen SH, Kristensen IB, Buene G, Mylin AK, Turesson I et al (2018) Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes. Biomark Res 6:21. https:\/\/doi.org\/10.1186\/s40364-018-0134-y","journal-title":"Biomark Res"},{"issue":"4","key":"10174_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1590\/2359-3997000000067","volume":"59","author":"A Bolsoni-Lopes","year":"2015","unstructured":"Bolsoni-Lopes A, Alonso-Vale MIC (2015) Lipolysis and lipases in white adipose tissue-an update. Arch Endocrinol Metab 59(4):335\u2013342. https:\/\/doi.org\/10.1590\/2359-3997000000067","journal-title":"Arch Endocrinol Metab"},{"issue":"7","key":"10174_CR61","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1007\/s10238-023-01174-2","volume":"23","author":"R Torcasio","year":"2023","unstructured":"Torcasio R, Cantafio MEG, Ikeda RK, Ganino L, Viglietto G, Amodio N (2023) Lipid metabolic vulnerabilities of multiple myeloma. Clin Exp Med 23(7):3373\u20133390. https:\/\/doi.org\/10.1007\/s10238-023-01174-2","journal-title":"Clin Exp Med"},{"issue":"7","key":"10174_CR62","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.clnu.2019.08.031","volume":"39","author":"E Mortaz","year":"2020","unstructured":"Mortaz E, Moloudizargari M, Khosravi A, Asghari MH, Movassaghi M, Varahram M, Vaezi M, Redegeld FA, Garssen J (2020) EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner. Clin Nutr 39(7):2137\u20132143. https:\/\/doi.org\/10.1016\/j.clnu.2019.08.031","journal-title":"Clin Nutr"},{"issue":"14","key":"10174_CR63","doi-asserted-by":"publisher","first-page":"11858","DOI":"10.18632\/oncotarget.24405","volume":"9","author":"M Moloudizargari","year":"2018","unstructured":"Moloudizargari M, Mortaz E, Asghari MH, Adcock IM, Redegeld FA, Garssen J (2018) Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review. Oncotarget 9(14):11858\u201311875. https:\/\/doi.org\/10.18632\/oncotarget.24405","journal-title":"Oncotarget"},{"issue":"4","key":"10174_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3892\/ijo.17.4.789","volume":"17","author":"LC Chiu","year":"2000","unstructured":"Chiu LC, Wan JM, Ooi VE (2000) Induction of apoptosis by dietary polyunsaturated fatty acids in human leukemic cells is not associated with DNA fragmentation. Int J Oncol 17(4):789\u2013796. https:\/\/doi.org\/10.3892\/ijo.17.4.789","journal-title":"Int J Oncol"},{"issue":"1\u20134","key":"10174_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.prostaglandins.2011.08.004","volume":"96","author":"ER Greene","year":"2011","unstructured":"Greene ER, Huang S, Serhan CN, Panigrahy D (2011) Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat 96(1\u20134):27\u201336. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.08.004","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"9","key":"10174_CR66","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/0006-2952(93)90447-5","volume":"45","author":"JE Kinsella","year":"1993","unstructured":"Kinsella JE, Black JM (1993) Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward L5178Y lymphoma cells. Biochem Pharmacol 45(9):1881\u20131887. https:\/\/doi.org\/10.1016\/0006-2952(93)90447-5","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10174_CR67","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jnutbio.2014.06.013","volume":"25","author":"J Abdi","year":"2014","unstructured":"Abdi J, Garssen J, Faber J, Redegeld FA (2014) Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. J Nutr Biochem 25(12):1254\u20131262. https:\/\/doi.org\/10.1016\/j.jnutbio.2014.06.013","journal-title":"J Nutr Biochem"},{"issue":"7","key":"10174_CR68","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1134\/S0006297917070082","volume":"82","author":"X Dai","year":"2017","unstructured":"Dai X, Li M, Geng F (2017) Omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53\/miR-34a\/Bcl-2 Axis. Biochemistry (Mosc) 82(7):826\u2013833. https:\/\/doi.org\/10.1134\/S0006297917070082","journal-title":"Biochemistry (Mosc)"},{"key":"10174_CR69","doi-asserted-by":"publisher","first-page":"174883","DOI":"10.1016\/j.ejphar.2022.174883","volume":"922","author":"J Chen","year":"2022","unstructured":"Chen J, Ruijtenbeek R, Garssen J, Redegeld FA (2022) Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells. Eur J Pharmacol 922:174883. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174883","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10174_CR70","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/cancers13061206","volume":"13","author":"M Newell","year":"2021","unstructured":"Newell M, Mazurak V, Postovit LM, Field CJ (2021) N-3 long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic acid, and the role of supplementation during cancer treatment: a scoping review of current clinical evidence. Cancers (Basel) 13(6):1206. https:\/\/doi.org\/10.3390\/cancers13061206","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10174_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.leukres.2014.12.010","volume":"39","author":"A Jurczyszyn","year":"2015","unstructured":"Jurczyszyn A, Czepiel J, Gdula-Argasi\u0144ska J, Pa\u015bko P, Czapkiewicz A, Librowski T, Perucki W, Butrym A, Castillo JJ, Skotnicki AB (2015) Plasma fatty acid profile in multiple myeloma patients. Leuk Res 39(4):400\u2013405. https:\/\/doi.org\/10.1016\/j.leukres.2014.12.010","journal-title":"Leuk Res"},{"issue":"10","key":"10174_CR72","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.leukres.2014.08.009","volume":"38","author":"A Jurczyszyn","year":"2014","unstructured":"Jurczyszyn A, Czepiel J, Gdula-Argasi\u0144ska J, Czapkiewicz A, Biesiada G et al (2014) Erythrocyte membrane fatty acids in multiple myeloma patients. Leuk Res 38(10):1260\u20131265. https:\/\/doi.org\/10.1016\/j.leukres.2014.08.009","journal-title":"Leuk Res"},{"issue":"17","key":"10174_CR73","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-12-2917","volume":"19","author":"L Puchades-Carrasco","year":"2013","unstructured":"Puchades-Carrasco L, Lecumberri R, Mart\u00ednez-L\u00f3pez J, Lahuerta JJ, Mateos MV et al (2013) Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission. Clin Cancer Res 19(17):4770\u20134779. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2917","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10174_CR74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S095442241400002X","volume":"27","author":"G Fr\u00fchbeck","year":"2014","unstructured":"Fr\u00fchbeck G, M\u00e9ndez-Gim\u00e9nez L, Fern\u00e1ndez-Formoso JA, Fern\u00e1ndez S, Rodr\u00edguez A (2014) Regulation of adipocyte lipolysis. Nutr Res Rev 27(1):63\u201393. https:\/\/doi.org\/10.1017\/S095442241400002X","journal-title":"Nutr Res Rev"},{"issue":"3","key":"10174_CR75","doi-asserted-by":"publisher","first-page":"10173","DOI":"10.1002\/jbm4.10173","volume":"3","author":"M Masarwi","year":"2019","unstructured":"Masarwi M, DeSchiffart A, Ham J, Reagan MR (2019) Multiple myeloma and fatty acid metabolism. JBMR Plus 3(3):10173. https:\/\/doi.org\/10.1002\/jbm4.10173","journal-title":"JBMR Plus"},{"issue":"3","key":"10174_CR76","doi-asserted-by":"publisher","first-page":"102525","DOI":"10.15252\/embj.2019102525","volume":"39","author":"E Clement","year":"2020","unstructured":"Clement E, Lazar I, Attan\u00e9 C, Carri\u00e9 L, Dauvillier S, Ducoux-Petit M et al (2020) Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells. EMBO J 39(3):102525. https:\/\/doi.org\/10.15252\/embj.2019102525","journal-title":"EMBO J"},{"issue":"10","key":"10174_CR77","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1194\/jlr.R083725","volume":"59","author":"I Lazar","year":"2018","unstructured":"Lazar I, Clement E, Attane C, Muller C, Nieto L (2018) A new role for extracellular vesicles: how small vesicles can feed tumors\u2019 big appetite. J Lipid Res 59(10):1793\u20131804. https:\/\/doi.org\/10.1194\/jlr.R083725","journal-title":"J Lipid Res"},{"issue":"4","key":"10174_CR78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G Van Niel","year":"2018","unstructured":"Van Niel G, D\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213\u2013228. https:\/\/doi.org\/10.1038\/nrm.2017.125","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10174_CR79","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.3390\/ijms20133236","volume":"20","author":"M Colombo","year":"2019","unstructured":"Colombo M, Giannandrea D, Lesma E, Basile A, Chiaramonte R (2019) Extracellular vesicles enhance multiple myeloma metastatic dissemination. Int J Mol Sci 20(13):3236. https:\/\/doi.org\/10.3390\/ijms20133236","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10174_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7150\/thno.27550","volume":"9","author":"L Zhang","year":"2019","unstructured":"Zhang L, Lei Q, Wang H, Xu C, Liu T, Kong F, Yang C, Yan G, Sun L, Zhao A et al (2019) Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease. Theranostics 9(1):196\u2013209. https:\/\/doi.org\/10.7150\/thno.27550","journal-title":"Theranostics"},{"issue":"6","key":"10174_CR81","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1182\/blood.2021013832","volume":"139","author":"C Panaroni","year":"2022","unstructured":"Panaroni C, Fulzele K, Mori T, Tat Siu K, Onyewadume Ch, Maebius A, Raje N (2022) Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood 139(6):876\u2013888. https:\/\/doi.org\/10.1182\/blood.2021013832","journal-title":"Blood"},{"key":"10174_CR82","doi-asserted-by":"publisher","first-page":"81184","DOI":"10.7554\/eLife.81184","volume":"12","author":"M Farrell","year":"2023","unstructured":"Farrell M, Fairfield H, Karam M, D\u2019Amico A, Murphy CS, Falank C et al (2023) Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling. Elife 12:81184. https:\/\/doi.org\/10.7554\/eLife.81184","journal-title":"Elife"},{"issue":"13","key":"10174_CR83","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/cancers13133328","volume":"13","author":"JA Moraes","year":"2021","unstructured":"Moraes JA, Encarna\u00e7\u00e3o C, Franco VA, Botelho LGX et al (2021) Adipose tissue-derived extracellular vesicles and the tumor microenvironment: revisiting the hallmarks of cancer. Cancers (Basel) 13(13):3328. https:\/\/doi.org\/10.3390\/cancers13133328","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10174_CR84","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/156800912802429274","volume":"12","author":"M Lionetti","year":"2012","unstructured":"Lionetti M, Agnelli L, Lombardi L, Tassone P, Neri A (2012) MicroRNAs in the pathobiology of multiple myeloma. Curr Cancer Drug Targets 12(7):823\u2013837. https:\/\/doi.org\/10.2174\/156800912802429274","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"10174_CR85","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10174_CR86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/or.2019.7160","volume":"42","author":"N Liu","year":"2019","unstructured":"Liu N, Yang J, Yuan R, Peng J, Liu L, Guo X (2019) Effects of miR-181a on the biological function of multiple myeloma. Oncol Rep 42(1):291\u2013300. https:\/\/doi.org\/10.3892\/or.2019.7160","journal-title":"Oncol Rep"},{"issue":"11","key":"10174_CR87","doi-asserted-by":"publisher","first-page":"8545","DOI":"10.1007\/s13277-015-3600-2","volume":"36","author":"J Peng","year":"2015","unstructured":"Peng J, Thakur A, Zhang S et al (2015) Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma. Tumor Biol 36(11):8545\u20138552. https:\/\/doi.org\/10.1007\/s13277-015-3600-2","journal-title":"Tumor Biol"},{"issue":"3","key":"10174_CR88","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1371\/journal.pone.0004699","volume":"4","author":"N Kl\u00f6ting","year":"2009","unstructured":"Kl\u00f6ting N, Berthold S, Kovacs P et al (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE 4(3):4699. https:\/\/doi.org\/10.1371\/journal.pone.0004699","journal-title":"PLoS ONE"},{"issue":"35","key":"10174_CR89","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1097\/MD.0000000000012081","volume":"97","author":"R Yuan","year":"2018","unstructured":"Yuan R, Liu N, Yang J, Peng J, Liu L, Guo X (2018) The expression and role of miR-181a in multiple myeloma. Medicine (Baltimore) 97(35):12081. https:\/\/doi.org\/10.1097\/MD.0000000000012081","journal-title":"Medicine (Baltimore)"},{"key":"10174_CR90","doi-asserted-by":"publisher","first-page":"6504593","DOI":"10.1155\/2016\/6504593","volume":"2016","author":"L Raimondi","year":"2016","unstructured":"Raimondi L, De Luca A, Morelli E et al (2016) MicroRNAs: novel crossroads between myeloma cells and the bone marrow microenvironment. Biomed Res Int 2016:6504593. https:\/\/doi.org\/10.1155\/2016\/6504593","journal-title":"Biomed Res Int"},{"issue":"12","key":"10174_CR91","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/jcp.24669","volume":"229","author":"M Leotta","year":"2014","unstructured":"Leotta M, Biamonte L, Raimondi L et al (2014) A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. J Cell Physiol 229(12):2106\u20132116. https:\/\/doi.org\/10.1002\/jcp.24669","journal-title":"J Cell Physiol"},{"issue":"1","key":"10174_CR92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13287-015-0116-z","volume":"6","author":"SR Baglio","year":"2015","unstructured":"Baglio SR, Rooijers K, Koppers-Lalic D et al (2015) Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 6(1):127. https:\/\/doi.org\/10.1186\/s13287-015-0116-z","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10174_CR93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12032-014-0094-5","volume":"31","author":"J Ma","year":"2014","unstructured":"Ma J, Liu S, Wang Y (2014) MicroRNA-21 and multiple myeloma: small molecule and big function. Med Oncol 31(8):94. https:\/\/doi.org\/10.1007\/s12032-014-0094-5","journal-title":"Med Oncol"},{"issue":"10","key":"10174_CR94","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3109\/10428194.2011.591004","volume":"52","author":"X Wang","year":"2011","unstructured":"Wang X, Li C, Ju S, Wang Y, Wang H, Zhong R (2011) Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation. Leuk Lymphoma 52(10):1991\u20131998. https:\/\/doi.org\/10.3109\/10428194.2011.591004","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10174_CR95","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/leu.2014.295","volume":"29","author":"ST Lwin","year":"2015","unstructured":"Lwin ST, Olechnowicz SWZ, Fowler JA, Edwards CM (2015) Diet-induced obesity promotes a myeloma-like condition in vivo. Leukemia 29(2):507\u2013510. https:\/\/doi.org\/10.1038\/leu.2014.295","journal-title":"Leukemia"},{"issue":"2","key":"10174_CR96","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/1120009X.2022.2062895","volume":"35","author":"Z Wu","year":"2023","unstructured":"Wu Z, Wu L, Zou L, Wang M, Liu X (2023) Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use. J Chemother 35(2):131\u2013141. https:\/\/doi.org\/10.1080\/1120009X.2022.2062895","journal-title":"J Chemother"},{"issue":"5","key":"10174_CR97","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","volume":"21","author":"S Dalva-Aydemir","year":"2015","unstructured":"Dalva-Aydemir S, Bajpai R, Martinez M, Adekola KU, Kandela I, Wei C et al (2015) Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin. Clin Cancer Res 21(5):1161\u20131171. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1088","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10174_CR98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/cco-23-157","volume":"13","author":"GS Paz","year":"2024","unstructured":"Paz GS, Fernandes J (2024) Metformin as a therapeutic tool for resistant hematological malignancies: a literature review. Chin Clin Oncol 13(3):39. https:\/\/doi.org\/10.21037\/cco-23-157","journal-title":"Chin Clin Oncol"},{"issue":"9","key":"10174_CR99","doi-asserted-by":"publisher","first-page":"46484","DOI":"10.1371\/journal.pone.0046484","volume":"7","author":"JM Tirado-V\u00e9lez","year":"2012","unstructured":"Tirado-V\u00e9lez JM, Joumady I, S\u00e1ez-Benito A, C\u00f3zar-Castellano I, Perdomo G (2012) Inhibition of fatty acid metabolism reduces human myeloma cells proliferation. PLoS ONE 7(9):46484. https:\/\/doi.org\/10.1371\/journal.pone.0046484","journal-title":"PLoS ONE"},{"issue":"8","key":"10174_CR100","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","volume":"8","author":"M Zhang","year":"2018","unstructured":"Zhang M, Di Martino JS, Bowman RL, Campbell NR, Baksh SC, Simon-Vermot T et al (2018) Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov 8(8):1006\u20131025. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1371","journal-title":"Cancer Discov"},{"issue":"1","key":"10174_CR101","doi-asserted-by":"publisher","first-page":"101042831773136","DOI":"10.1177\/1010428317731369","volume":"40","author":"J Ma","year":"2018","unstructured":"Ma J, Gong W, Liu S, Li Q, Guo M, Wang J, Wang S, Chen N, Wang Y, Liu Q, Zhao H (2018) Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-\u03baB and STAT3. Tumour Biol 40(1):1010428317731369. https:\/\/doi.org\/10.1177\/1010428317731369","journal-title":"Tumour Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10174-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:34:41Z","timestamp":1766853281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10174-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10174"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10174-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary file has been removed","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"74"}}